PEGylated protein drugs: basic science and clinical applications
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Basel [u.a.]
Birkhäuser
2009
|
| Schriftenreihe: | Milestones in drug therapy
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | IX, 287 S. Ill., graph. Darst. |
| ISBN: | 9783764386788 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV035381827 | ||
| 003 | DE-604 | ||
| 005 | 20100611 | ||
| 007 | t | ||
| 008 | 090319s2009 ad|| |||| 00||| eng d | ||
| 015 | |a 08,N32,0527 |2 dnb | ||
| 016 | 7 | |a 989664961 |2 DE-101 | |
| 020 | |a 9783764386788 |c Gb. : EUR 127.33 (freier Pr.), sfr 209.00 (freier Pr.) |9 978-3-7643-8678-8 | ||
| 024 | 3 | |a 9783764386788 | |
| 028 | 5 | 2 | |a 12105410 |
| 035 | |a (OCoLC)492186603 | ||
| 035 | |a (DE-599)DNB989664961 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 |a DE-M49 | ||
| 050 | 0 | |a TP248.65.P58 | |
| 082 | 0 | |a 615.19 |2 22/ger | |
| 084 | |a VX 8550 |0 (DE-625)147830:253 |2 rvk | ||
| 084 | |a XI 1600 |0 (DE-625)152976:12905 |2 rvk | ||
| 084 | |a CHE 893f |2 stub | ||
| 084 | |a 610 |2 sdnb | ||
| 084 | |a CIT 840f |2 stub | ||
| 245 | 1 | 0 | |a PEGylated protein drugs |b basic science and clinical applications |c ed. by Francesco M. Veronese |
| 264 | 1 | |a Basel [u.a.] |b Birkhäuser |c 2009 | |
| 300 | |a IX, 287 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Milestones in drug therapy | |
| 650 | 4 | |a Drug Carriers |x therapeutic use | |
| 650 | 4 | |a Drugs |x Design | |
| 650 | 4 | |a Polyethylene Glycols |x therapeutic use | |
| 650 | 4 | |a Polyethylene glycol | |
| 650 | 4 | |a Protein drugs | |
| 650 | 4 | |a Proteins |x therapeutic use | |
| 650 | 0 | 7 | |a Proteide |0 (DE-588)4123993-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Polyethylenglykolderivate |0 (DE-588)4325470-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Polyethylenglykolderivate |0 (DE-588)4325470-6 |D s |
| 689 | 0 | 1 | |a Proteide |0 (DE-588)4123993-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Veronese, Francesco M. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186074&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-017186074 | ||
Datensatz im Suchindex
| _version_ | 1804138711688937472 |
|---|---|
| adam_text | Contents
List of contributors
.........................................
VII
Ruth Duncan and Francesco M. Veronese
Preface: PEGylated protein conjugates: A new class of therapeutics
for the 21st century
........................................ 1
Francesco M. Veronese, Anna Mew and
Gianfranco Pasut
Protein PEGylation, basic science and biological applications
....... 11
Gian
Maria Bonora and Sara Drioli
Reactive PEGs for protein conjugation
......................... 33
Л
-Won
Choi, Antony Godwin, Sibu
Balan,
Penny Bryant, Yuehua
Cong,
Estera
Pawlisz,
Manuchehr Porssa, Norbert Rumpf, Ruchi
Singh, Keith Powell and Steve Brocchini
Rebridging disulphides: site-specific PEGylation by sequential
bis-alkylation
............................................. 47
Mauro Sergi, Francesco Caboi, Carlo Maullu, Gaetano Orsini
and Giuncarlo Tonon
Enzymatic techniques for
PEGylation
of biopharmaceuticals
....... 75
Angelo Fontana, Barbara Spolaore, Anna Mero and
Francesco M. Veronese
The site-specific TGase-mediated
PEGylation
of proteins occurs
at flexible sites
............................................ 89
Conan J. Fee
Protein conjugates purification and characterization
............... 113
Rob Webster, Victoria Elliott, B. Kevin Park, Donald Walker,
Mark
Hankin
and Philip Taupin
PEG and PEG conjugates
toxicity:
towards an understanding of
the
toxicity
of PEG and its relevance to PEGylated biologicals
...... 127
Jonathan K. Armstrong
The occurrence, induction, specificity and potential effect of
antibodies against poly(ethylene
glycol)
........................ 147
VI
Contents
Graham Molineux
Pegfilgrastim -
designing an improved form of rmetttuG-CSF
...... 169
Rory F.
Finn
PEGylation
of
human
growth hormone: strategies and properties
.... 187
Gianfranco Pasut
PEGyłated
α
interferons:
two different strategies to achieve increased
efficacy
.................................................. 205
Michael S. Hershfield, John S. Sundy, Nancy J. Ganson and
Susan J. Kelly
Development of PEGylated mammalian
urate oxidase
as a therapy
for patients with refractory gout
.............................. 217
Andrew M. Nesbitt, Sue Stephens and Elliot K. Chartash
Certolizumab pegol: a PEGylated anti-tumour necrosis factor alpha
biological agent
........................................... 229
Anna
Mero, Gianfranco
Pasut and Francesco M. Veronese
PEG: a useful technology in
anticancer
therapy
.................. 255
Tacey X. Viegas and Francesco M. Veronese
Regulatory strategy and approval processes considered for
PEG-drag conjugates and other nanomedicines
.................. 273
Index
.................................................... 283
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV035381827 |
| callnumber-first | T - Technology |
| callnumber-label | TP248 |
| callnumber-raw | TP248.65.P58 |
| callnumber-search | TP248.65.P58 |
| callnumber-sort | TP 3248.65 P58 |
| callnumber-subject | TP - Chemical Technology |
| classification_rvk | VX 8550 XI 1600 |
| classification_tum | CHE 893f CIT 840f |
| ctrlnum | (OCoLC)492186603 (DE-599)DNB989664961 |
| dewey-full | 615.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.19 |
| dewey-search | 615.19 |
| dewey-sort | 3615.19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Chemie Chemie-Ingenieurwesen Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02080nam a2200553 c 4500</leader><controlfield tag="001">BV035381827</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100611 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090319s2009 ad|| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">08,N32,0527</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">989664961</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783764386788</subfield><subfield code="c">Gb. : EUR 127.33 (freier Pr.), sfr 209.00 (freier Pr.)</subfield><subfield code="9">978-3-7643-8678-8</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783764386788</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">12105410</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)492186603</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB989664961</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-M49</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TP248.65.P58</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 8550</subfield><subfield code="0">(DE-625)147830:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1600</subfield><subfield code="0">(DE-625)152976:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CHE 893f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CIT 840f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">PEGylated protein drugs</subfield><subfield code="b">basic science and clinical applications</subfield><subfield code="c">ed. by Francesco M. Veronese</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Birkhäuser</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IX, 287 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Milestones in drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Carriers</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polyethylene Glycols</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polyethylene glycol</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteins</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteide</subfield><subfield code="0">(DE-588)4123993-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Polyethylenglykolderivate</subfield><subfield code="0">(DE-588)4325470-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Polyethylenglykolderivate</subfield><subfield code="0">(DE-588)4325470-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Proteide</subfield><subfield code="0">(DE-588)4123993-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Veronese, Francesco M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186074&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017186074</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV035381827 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T21:32:32Z |
| institution | BVB |
| isbn | 9783764386788 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017186074 |
| oclc_num | 492186603 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-M49 DE-BY-TUM |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-M49 DE-BY-TUM |
| physical | IX, 287 S. Ill., graph. Darst. |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Birkhäuser |
| record_format | marc |
| series2 | Milestones in drug therapy |
| spelling | PEGylated protein drugs basic science and clinical applications ed. by Francesco M. Veronese Basel [u.a.] Birkhäuser 2009 IX, 287 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Milestones in drug therapy Drug Carriers therapeutic use Drugs Design Polyethylene Glycols therapeutic use Polyethylene glycol Protein drugs Proteins therapeutic use Proteide (DE-588)4123993-3 gnd rswk-swf Polyethylenglykolderivate (DE-588)4325470-6 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Polyethylenglykolderivate (DE-588)4325470-6 s Proteide (DE-588)4123993-3 s DE-604 Veronese, Francesco M. Sonstige oth Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186074&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | PEGylated protein drugs basic science and clinical applications Drug Carriers therapeutic use Drugs Design Polyethylene Glycols therapeutic use Polyethylene glycol Protein drugs Proteins therapeutic use Proteide (DE-588)4123993-3 gnd Polyethylenglykolderivate (DE-588)4325470-6 gnd |
| subject_GND | (DE-588)4123993-3 (DE-588)4325470-6 (DE-588)4143413-4 |
| title | PEGylated protein drugs basic science and clinical applications |
| title_auth | PEGylated protein drugs basic science and clinical applications |
| title_exact_search | PEGylated protein drugs basic science and clinical applications |
| title_full | PEGylated protein drugs basic science and clinical applications ed. by Francesco M. Veronese |
| title_fullStr | PEGylated protein drugs basic science and clinical applications ed. by Francesco M. Veronese |
| title_full_unstemmed | PEGylated protein drugs basic science and clinical applications ed. by Francesco M. Veronese |
| title_short | PEGylated protein drugs |
| title_sort | pegylated protein drugs basic science and clinical applications |
| title_sub | basic science and clinical applications |
| topic | Drug Carriers therapeutic use Drugs Design Polyethylene Glycols therapeutic use Polyethylene glycol Protein drugs Proteins therapeutic use Proteide (DE-588)4123993-3 gnd Polyethylenglykolderivate (DE-588)4325470-6 gnd |
| topic_facet | Drug Carriers therapeutic use Drugs Design Polyethylene Glycols therapeutic use Polyethylene glycol Protein drugs Proteins therapeutic use Proteide Polyethylenglykolderivate Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186074&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT veronesefrancescom pegylatedproteindrugsbasicscienceandclinicalapplications |